|
| Press Releases |
|
 |
|
| Friday, June 13, 2025 |
|
|
Jacobson Pharma Announces FY2025 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing, and sale of essential medicines and specialty drugs, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2025 ("FY2025" or the "Reporting Period"). more info >> |
|
|
雅各臣公佈二零二五財年全年業績 持續經營業務溢利飈升43.1％至3.0億港元 |
| 從事基礎藥物及專科藥物研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司（「雅各臣」或「公司」；股份代號：2633.HK）今天公佈公司及其附屬公司（統稱「集團」）截至二零二五年三月三十一日止年度（「二零二五財年」或「報告期」）的全年業績。 more info >> |
|
|
雅各臣公布二零二五财年全年业绩 持续经营业务溢利飙升43.1％至3.0亿港元 |
| 从事基础药物及专科药物研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司（「雅各臣」或「公司」；股份代号：2633.HK）今天公布公司及其附属公司（统称「集团」）截至二零二五年三月三十一日止年度（「二零二五财年」或「报告期」）的全年业绩。 more info >> |
|
| Friday, November 22, 2024 |
|
|
Jacobson Pharma Announces FY2025 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines and specialty drugs, today announced the interim results of the Company and its subsidiaries (collectively, the "Group") for the six months ended 30 September 2024 (the "Reporting Period"). more info >> |
|
|
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2% |
| 從事基礎藥物及專科藥物研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司（「雅各臣」或「公司」；股份代號：2633.HK）今天公佈公司及其附屬公司（統稱「集團」）於截至二零二四年九月三十日止六個月（「報告期」）的中期業績。 more info >> |
|
| Friday, November 25, 2022 |
|
|
雅各臣公布二零二三财年中期业绩 |
| 从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司 （「 雅各臣 」 或 「 公司 」；股份代号 2633.HK ) 今天公布公司及其附属公司（统称「集团」）于截至二零二二年九月三十日止年度（「报告期」）的中期业绩。 more info >> |
|
|
雅各臣公佈二零二三財年中期業績 |
| 從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司 （「 雅各臣 」 或 「 公司 」；股份代號 2633.HK ) 今天公佈公司及其附屬公司（統稱「集團」）於截至二零二二年九月三十日止年度（「報告期」）的中期業績。 more info >> |
|
|
Jacobson Pharma Announces FY2023 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2022 (the "Reporting Period"). more info >> |
|
| Wednesday, June 29, 2022 |
|
|
雅各臣公布二零二二财年全年业绩 |
从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司 （「 雅各臣 」或「 公司 」； 股份代号： 2633.HK )今天公布公司及其附属公司（统称「集团」）于截至二零二二年三月三十一日止年度（「二零二二财年」或「报告期」）的全年业绩。
more info >> |
|
|
雅各臣公佈二零二二財年全年業績 |
| 從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司 （「 雅各臣 」或「 公司 」； 股份代號： 2633.HK )今天公佈公司及其附屬公司（統稱「集團」）於截至二零二二年三月三十一日止年度（「二零二二財年」或「報告期」）的全年業績。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
maxWin Sports Makes It Debut in Motorsports with EBM-GIGA Racing Team
Jul 16, 2025 09:00: JST
|
|
|
maxWin Sports Makes It Debut in Motorsports with EBM-GIGA Racing Team
Jul 16, 2025 08:00 HKT/SGT
|
|
|
耀啟新程！康哲藥業今日於新加坡交易所主板實現二次上市
Jul 15, 2025 23:54 HKT/SGT
|
|
|
U.S. Polo Assn. Celebrates Seventh Year Supporting the 2025 Outsourcing Inc. Royal Charity Polo Cup
Jul 15, 2025 23:14 HKT/SGT
|
|
|
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
Jul 15, 2025 23:13 HKT/SGT
|
|
|
Formerra to Supply Foster Medical Compounds Across the Americas
Jul 15, 2025 22:50 HKT/SGT
|
|
|
Buy International Homes at the Global Property Expo, Singapore
Jul 15, 2025 20:06 HKT/SGT
|
|
|
XDS Datacentres signs 15-year deal to host 10MW of AI workloads in Saudi's Desert Dragons facilities
Jul 15, 2025 19:41 HKT/SGT
|
|
|
Ocean One Seizing Business Opportunities with Main Board Listing Application
Jul 15, 2025 19:00 HKT/SGT
|
|
|
大洋環球申轉主板上市捉緊商機 迎中國恢復部分日本水產進口機遇
Jul 15, 2025 18:22 HKT/SGT
|
|
|
大洋环球申转主板上市捉紧商机 迎中国恢复部分日本水产进口机遇
Jul 15, 2025 18:10 HKT/SGT
|
|
|
雲頂新耀股價創階段新高 通用型現貨腫瘤治療性疫苗EVM14「中美雙報」再釋mRNA平台潛力
Jul 15, 2025 17:40 HKT/SGT
|
|
|
云顶新耀股价创阶段新高 通用型现货肿瘤治疗性疫苗EVM14"中美双报"再释mRNA平台潜力
Jul 15, 2025 17:34 HKT/SGT
|
|
|
耀启新程！康哲药业今日于新加坡交易所主板实现二次上市
Jul 15, 2025 16:53 HKT/SGT
|
|
|
ONERHT Foundation Announces 8th edition of GAIL Forum which will focus on Green Leadership in ASEAN
Jul 15, 2025 13:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
